Yaşar Murat Elçin

Prof. Dr. Yaşar Murat Elçin

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2016 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
MPMahmut Parmaksiz
Mahmut Parmaksiz
ADArin Dogan
Arin Dogan
SOSedat Odabas
Sedat Odabas
AEA Eser Elçin
A Eser Elçin
Yaşar Murat ElçinYaşar Murat Elçin
Yaşar Murat Elçin
Decellularization is the process of removing the cellular components from tissues or organs. It is a promising technology for obtaining a biomaterial with a highly preserved extracellular matrix (ECM), which may also act as a biological scaffold for tissue engineering and regenerative therapies. Decellularized products are gaining clinical importance and market space due to their ease of standardized production, constant availability for grafting and mechanical or biochemical superiority against competing clinical options, yielding clinical results ahead of the ones with autografts in some applications. Current drawbacks and limitations of traditional treatments and clinical applications can be overcome by using decellularized or acellular matrices. Several companies are leading the market with versatile acellular products designed for diverse use in the reconstruction of tissues and organs. This review describes ECM-based decellularized and acellular products that are currently in use for different branches of clinic.

2 April 2020 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Closed access
FAFatma Betül Ayanoğlu
Fatma Betül Ayanoğlu
AEAyşe Eser ELÇİN
Ayşe Eser ELÇİN
Yaşar Murat ElçinYaşar Murat Elçin
Yaşar Murat Elçin
Genome editing technologies have led to fundamental changes in genetic science. Among them, CRISPR-Cas9 technology particularly stands out due to its advantages such as easy handling, high accuracy, and low cost. It has made a quick introduction in fields related to humans, animals, and the environment, while raising difficult questions, applications, concerns, and bioethical issues to be discussed. Most concerns stem from the use of CRISPR-Cas9 to genetically alter human germline cells and embryos (called germline genome editing). Germline genome editing leads to serial bioethical issues, such as the occurrence of undesirable changes in the genome, from whom and how informed consent is obtained, and the breeding of the human species (eugenics). However, the bioethical issues that CRISPR-Cas9 technology could cause in the environment, agriculture and livestock should also not be forgotten. In order for CRISPR-Cas9 to be used safely in all areas and to solve potential issues, worldwide legislation should be prepared, taking into account the opinions of both life and social scientists, policy makers, and all other stakeholders of the sectors, and CRISPR-Cas9 applications should be implemented according to such legislations. However, these controls should not restrict scientific freedom. Here, various applications of CRISPR-Cas9 technology, especially in medicine and agriculture, are described and ethical issues related to genome editing using CRISPR-Cas9 technology are discussed. The social and bioethical concerns in relation to human beings, other organisms, and the environment are addressed.


29 May 2023 in Advances in Colloid and Interface Science
Verified
Journal Article
Closed access
SKSeyithan Kansız
Seyithan Kansız
Yaşar Murat ElçinYaşar Murat Elçin
Yaşar Murat Elçin

19 May 2008 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
BIBülend Inanç
Bülend Inanç
YAYavuz Emre ARSLAN
Yavuz Emre ARSLAN
SSSukran Seker
Sukran Seker
AEA. Eser Elçin
A. Eser Elçin
Yaşar Murat ElçinYaşar Murat Elçin
Yaşar Murat Elçin

1 February 2006 in Tissue Engineering
Verified
Journal Article
Closed access
BIBülend Inanc
Bülend Inanc
AEA. Eser Elcin
A. Eser Elcin
Yaşar Murat ElçinYaşar Murat Elçin
Yaşar Murat Elçin
Human periodontal ligament fibroblasts (hPDLF) play a key role in the regeneration of periodontal compartment during guided tissue regeneration procedures. This property is attributed to the progenitor cell subsets residing in the area. The aim of this study was to investigate whether hPDLFs could undergo an osteogenic differentiation under two- and three-dimensional (2D and 3D) culture conditions upon osteogenic induction. hPDLFs were isolated from six healthy donors, cultured, and expanded according to standard protocols. Then, three osteogenic culture conditions (dexamethasone, ascorbic acid, and beta-glycerophosphate) were established: 1) 2D culture as single-cell monolayer, 2) 3D-static culture on mineralized poly(DL-lactic-co-glycolic acid) (PLGA) scaffold, and 3) 3D culture on mineralized PLGA scaffold inside the NASA-approved bioreactor stimulating microgravity conditions. After 21 days of osteogenic induction, the majority of monolayer cultures had undergone differentiation toward osteogenic lineage, as indicated by morphological changes, mineralization assay, and some phenotypical properties. However, immunohistochemistry revealed that the scaffold cultures expressed higher levels of osteogenic marker proteins compared with that of the monolayers. Secondly, hPDLF-PLGA constructs in bioreactor showed an increased expression of osteopontin and osteocalcin compared with that of static 3D culture after 21 days. Results indicate that human periodontal ligament contains a subpopulation of cells capable of undergoing osteogenic differentiation and presumably contributing to regeneration of bone defects in the adjacent area. Human PDLF-seeded mineralized PLGA scaffold in microgravity bioreactor may be used to support osteogenic differentiation in vitro. Thus, this system may offer new potential benefits as a tool for periodontal tissue engineering.